Thoratec Corporation

	Nasdaq: THOR	Change symbol:

NEWS FROM THE WIRES Thoratec Corp. names Wayne Boylston CFO Aug 06 2001 05:52 AM PDT U.S. stocks slip further; Greenspan speaks Jul 24 2001 08:43 AM PDT Thoratec reports second-quarter loss Jul 24 2001 06:10 AM PDT > More WIRE STORIES about this company  PROFILE Suffering from a broken heart? Thoratec's there for the rebound. The company makes artificial heart devices for patients awaiting a heart transplant. Its lead product, the FDA-approved Ventricular Assist Device (VAD), uses a blood pump, a console to activate the pump, and tubes linking the pump to the heart. The pump is worn outside the body, allowing for patient mobility. Thoratec is also developing HeartMate, an implantable heart-assist device. Other products include Aria (in clinical trials) and Vectra, small grafts used in hemodialysis and coronary artery bypass surgery. Thoratec bought its rival, Thermo Cardiosystems, and has a distribution pact with Guidant.  COMPETITION ABIOMED, Inc. (ABMD) Arrow International, Inc. (ARRO) World Heart Corporation (WHRT)		STOCK ANALYSIS  View by:  Day   Day   Month   Month   Year   Year  FURTHER ANALYSIS • Advanced Charting • Deals  FINANCIAL OVERVIEW Fiscal Year-End: December 2000 Sales (mil.): 30.40 1-Yr. Sales Growth: 35.1% Employees: 183 Revenue per employee: $166,120.22  KEY PEOPLE • D. Keith Grossman     CEO • Cheryl D. Hess     CFO  CONTACT INFO 6035 Stoneridge Drive Pleasanton, CA 94588 US Phone: 925-847-8600 Fax: 925-847-8574 Online: Web Site

	Company Data   News, quotes & more

		Hoover's Company Capsule Copyright © 2001, Hoover's Inc. Austin, Texas. For changes and updates, contact Hoover's directly.